Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia. (Q51741902)
Jump to navigation
Jump to search
scientific article published in January 1990
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia. |
scientific article published in January 1990 |
Statements
Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia. (English)
1 reference
P J Adnet
1 reference
R M Krivosic-Horber
1 reference
M M Adamantidis
1 reference
G Haudecoeur
1 reference
G H Reyfort
1 reference
B A Dupuis
1 reference
1 January 1990
1 reference
64
1 reference
1
1 reference
64-66
1 reference